Antibody tests for identification of current and past infection with SARS‐CoV‐2

T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

Lateral flow assays for viruses diagnosis: Up-to-date technology and future prospects

B Ince, MK Sezgintürk - TrAC Trends in Analytical Chemistry, 2022 - Elsevier
Bacteria, viruses, and parasites are harmful microorganisms that cause infectious diseases.
Early detection of diseases is critical to prevent disease transmission and provide epidemic …

SERS based lateral flow immunoassay for point-of-care detection of SARS-CoV-2 in clinical samples

S Yadav, MA Sadique, P Ranjan, N Kumar… - ACS Applied Bio …, 2021 - ACS Publications
The current scenario, an ongoing pandemic of COVID-19, places a dreadful burden on the
healthcare system worldwide. Subsequently, there is a need for a rapid, user-friendly, and …

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: serologic testing (September 2020)

KE Hanson, AM Caliendo, CA Arias… - Clinical Infectious …, 2024 - academic.oup.com
Background The availability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) serologic testing has rapidly increased. Current assays use a variety of technologies …

Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects

Y Rasmi, X Li, J Khan, T Ozer, JR Choi - Analytical and bioanalytical …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) pandemic is currently a serious global
health threat. While conventional laboratory tests such as quantitative real-time polymerase …

Anti-SARS-CoV-2 IgM/IgG antibodies detection using a patch sensor containing porous microneedles and a paper-based immunoassay

L Bao, J Park, B Qin, B Kim - Scientific Reports, 2022 - nature.com
Infectious diseases are among the leading causes of mortality worldwide. A new coronavirus
named severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) was identified in …

[HTML][HTML] SERS immuno-and apta-assays in biosensing/bio-detection: Performance comparison, clinical applications, challenges

A Ilyas, A Dyussupova, A Sultangaziyev, Y Shevchenko… - Talanta, 2023 - Elsevier
Abstract Surface Enhanced Raman Spectroscopy is increasingly used as a sensitive
bioanalytical tool for detection of variety of analytes ranging from viruses and bacteria to …

Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives

T Dong, M Wang, J Liu, P Ma, S Pang, W Liu… - Chemical Science, 2023 - pubs.rsc.org
The disastrous spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has induced severe public healthcare issues and weakened the global economy …

Recent advances in sensitive surface-enhanced Raman scattering-based lateral flow assay platforms for point-of-care diagnostics of infectious diseases

K Kim, L Kashefi-Kheyrabadi, Y Joung, K Kim… - Sensors and Actuators B …, 2021 - Elsevier
This review reports the recent advances in surface-enhanced Raman scattering (SERS)-
based lateral flow assay (LFA) platforms for the diagnosis of infectious diseases. As …

New technologies and reagents in lateral flow assay (LFA) designs for enhancing accuracy and sensitivity

MK Dey, M Iftesum, R Devireddy, MR Gartia - Analytical Methods, 2023 - pubs.rsc.org
Lateral flow assays (LFAs) are a popular method for quick and affordable diagnostic testing
because they are easy to use, portable, and user-friendly. However, LFA design has always …